• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

OncoMed Pharmaceuticals Inc

+ Add to Watchlist

OMED:US

17.1600 USD 0.8400 4.67%

As of 20:10:00 ET on 09/19/2014.

Company Profile for OncoMed Pharmaceuticals Inc (OMED)

OncoMed Pharmaceuticals, Inc. provides biotechnology research and development. The Company synthesizes oncogenic mutations in stem cells that allows the cells to grow without normal limitations in attempts to exploit therapies that selectively target tumor initiating cells. OncoMed Pharmaceuticals serves the healthcare industry and cancer therapy patients in the United States.

Contact Information

OncoMed Pharmaceuticals Inc

800 Chesapeake Drive
Redwood City, CA 94063
United States
Phone: 1-650-995-8200
Fax: 1-650-298-8600

Key Executives for OncoMed Pharmaceuticals Inc (OMED)

Paul J HastingsChairman/President/CEOJohn A LewickiExec VP/Chief Scientific Ofcr
Sunil PatelSenior VP:Corporate Dev/CFOJakob DupontSenior VP/Chief Medical Ofcr
Alicia J HagerVP/General Counsel

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil